Cargando…
Memantine potentiates cytarabine-induced cell death of acute leukemia correlating with inhibition of K(v)1.3 potassium channels, AKT and ERK1/2 signaling
BACKGROUND: Treatment of acute leukemia is challenging and long-lasting remissions are difficult to induce. Innovative therapy approaches aim to complement standard chemotherapy to improve drug efficacy and decrease toxicity. Promising new therapeutic targets in cancer therapy include voltage-gated...
Autores principales: | Lowinus, Theresa, Heidel, Florian H., Bose, Tanima, Nimmagadda, Subbaiah Chary, Schnöder, Tina, Cammann, Clemens, Schmitz, Ingo, Seifert, Ulrike, Fischer, Thomas, Schraven, Burkhart, Bommhardt, Ursula |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6335768/ https://www.ncbi.nlm.nih.gov/pubmed/30651113 http://dx.doi.org/10.1186/s12964-018-0317-z |
Ejemplares similares
-
Immunomodulation by memantine in therapy of Alzheimer's disease is mediated through inhibition of K(v)1.3 channels and T cell responsiveness
por: Lowinus, Theresa, et al.
Publicado: (2016) -
NMDA-receptor antagonists block B-cell
function but foster IL-10 production in BCR/CD40-activated B cells
por: Simma, Narasimhulu, et al.
Publicado: (2014) -
Beyond TCR Signaling: Emerging Functions of Lck in Cancer and Immunotherapy
por: Bommhardt, Ursula, et al.
Publicado: (2019) -
Type of PaperY192 within the SH2 Domain of Lck Regulates TCR Signaling Downstream of PLC-γ1 and Thymic Selection
por: Kästle, Matthias, et al.
Publicado: (2022) -
Low-dose metformin and PEN2-dependent lysosomal AMPK activation: benefits outnumber side effects
por: Liu, Longlong, et al.
Publicado: (2022)